Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
Extraintestinal manifestations (EIMs) are common in patients with ulcerative colitis (UC) and can have a significant impact on patient morbidity and quality of life. We assessed the effect of adalimumab (ADA) therapy on the resolution of EIMs among patients with moderate to severe UC in clinical pra...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Oxford University Press
2017
|
| _version_ | 1797105359888842752 |
|---|---|
| author | Travis, S Feagan, B Peyrin-Biroulet, L Panaccione, R Danese, S Lazar, A Robinson, A Thakkar, R Pappalardo, B Petersson, J Bereswill, M Chen, N Skup, M |
| author_facet | Travis, S Feagan, B Peyrin-Biroulet, L Panaccione, R Danese, S Lazar, A Robinson, A Thakkar, R Pappalardo, B Petersson, J Bereswill, M Chen, N Skup, M |
| author_sort | Travis, S |
| collection | OXFORD |
| description | Extraintestinal manifestations (EIMs) are common in patients with ulcerative colitis (UC) and can have a significant impact on patient morbidity and quality of life. We assessed the effect of adalimumab (ADA) therapy on the resolution of EIMs among patients with moderate to severe UC in clinical practice. |
| first_indexed | 2024-03-07T06:46:24Z |
| format | Journal article |
| id | oxford-uuid:fafe07fe-9a19-4ccc-890c-f8013985576e |
| institution | University of Oxford |
| last_indexed | 2024-03-07T06:46:24Z |
| publishDate | 2017 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:fafe07fe-9a19-4ccc-890c-f8013985576e2022-03-27T13:10:34ZEffect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADAJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:fafe07fe-9a19-4ccc-890c-f8013985576eSymplectic Elements at OxfordOxford University Press2017Travis, SFeagan, BPeyrin-Biroulet, LPanaccione, RDanese, SLazar, ARobinson, AThakkar, RPappalardo, BPetersson, JBereswill, MChen, NSkup, MExtraintestinal manifestations (EIMs) are common in patients with ulcerative colitis (UC) and can have a significant impact on patient morbidity and quality of life. We assessed the effect of adalimumab (ADA) therapy on the resolution of EIMs among patients with moderate to severe UC in clinical practice. |
| spellingShingle | Travis, S Feagan, B Peyrin-Biroulet, L Panaccione, R Danese, S Lazar, A Robinson, A Thakkar, R Pappalardo, B Petersson, J Bereswill, M Chen, N Skup, M Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA |
| title | Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA |
| title_full | Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA |
| title_fullStr | Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA |
| title_full_unstemmed | Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA |
| title_short | Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA |
| title_sort | effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting results from inspirada |
| work_keys_str_mv | AT traviss effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT feaganb effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT peyrinbirouletl effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT panaccioner effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT daneses effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT lazara effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT robinsona effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT thakkarr effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT pappalardob effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT peterssonj effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT bereswillm effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT chenn effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada AT skupm effectofadalimumabonextraintestinalmanifestationsamongpatientswithulcerativecolitisinaclinicalpracticesettingresultsfrominspirada |